Portfolio Update

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc All information is at 31 March 2009 and unaudited. Performance at month end with net income reinvested One Three One Three Since Launch Month Months Year Years (20 Sep 04) Net asset value 4.9% -16.4% -27.6% -22.9% 28.6% Share price 0.9% -19.2% -31.1% -26.5% 17.6% FTSE World Europe ex UK 8.2% -16.0% -31.1% -15.8% 22.0% Sources: BlackRock and Datastream At month end Net asset value (capital only): 120.36p Net asset value (including income): 121.00p* * includes net revenue of 0.64p Share price: 110.50p Discount to NAV (capital only): 8.2% Discount to NAV (including income): 8.7% Gearing (capital only): 0.0% Net yield: 2.7% Total assets (capital only): £128.6m Ordinary shares in issue: 106,820,690** ** Excluding 5,568,268 shares held in treasury. Benchmark Sector Analysis Total Assets Index (%) Country Analysis Total Assets (%) (%) Financials 20.8 21.3 France 30.8 Health Care 13.5 10.3 Germany 17.5 Telecommunications 10.2 8.7 Spain 12.3 Consumer Services 10.1 5.8 Switzerland 11.8 Industrials 9.8 12.3 Netherlands 9.3 Consumer Goods 8.8 14.6 Emerging Europe 6.8 Oil & Gas 7.5 8.0 Denmark 3.8 Technology 4.6 3.9 Italy 2.5 Utilities 4.3 8.7 Portugal 2.2 Basic Materials 2.6 6.4 Finland 1.3 Other Investments 6.8 Russia 0.5 Net current assets 1.0 Israel 0.2 ----- ----- Net current assets 1.0 100.0 100.0 ----- ===== ===== 100.0 ===== Ten Largest Equity Investments Company Country of Risk Banco Santander Spain BlackRock Eurasian Frontiers Hedge Fund Emerging Europe Credit Suisse Switzerland Koninklijke Netherlands Nestlé Switzerland Novo-Nordisk Denmark Sanofi-Aventis France Telefónica Spain Total France Vivendi Universal France Commenting on the markets, Vincent Devlin, representing the Investment Manager noted: After a weak start to the year European equity markets posted positive gains during March as investors welcomed news flow on relief packages to the troubled financials and aggressive monetary easing policies employed in the US and UK. Against this backdrop, the FTSE Europe ex UK returned 8.2%. During the month there was rapid sector rotation within the market and defensive sectors which had been strong relative performers year to date lagged, while financials and technology outperformed. During the month the Company's NAV returned 4.9%, underperforming the reference index. The contribution from the Emerging Europe region was negative due to the BlackRock Eurasian Frontiers Hedge Fund which underperformed the wider market despite delivering a positive return. The Company held a small residual cash balance through the month which had a negative contribution in a rising market. During the month, the Company suffered from its exposure to a number of defensive stocks especially within the Health Care sector that lagged in a market rally led by stocks with weaker balance sheets and sensitivity to the economic recovery. Specifically, the Company's holdings in Fresenius Medical Care, Novo-Nordisk and Nestlé detracted. Elsewhere, selected holdings in Media and Automobiles were also negative. The Company benefited from stock selection within the Financial sector, especially banks, where holdings in Credit Suisse, Société Générale, Unicredit and Intesa were positive, but also Insurance through positions in Zurich Financial Services and Allianz. During the month the Company increased its exposure to the Financial sector, by adding to banks and Insurance. Key transactions included the purchase of holdings in insurance company Allianz, and French banks BNP Paribas and Société Générale. Elsewhere, the Company added to selected companies with cyclical characteristics where valuations were reflecting an overly pessimistic outlook; this resulted in additions to the Information Technology, Materials and Automobiles sectors. The Company reduced its exposure to defensive names within Health Care, Consumer Staples and Utilities which had performed well in January and February. Exposure to emerging Europe remained roughly stable during the month at 7.5%. The BlackRock Eurasian Frontiers Hedge Fund accounted for the majority of the emerging market weight, providing diversified exposure to the region. Net market exposure ended the month at 99.0%. On a sector view, the Company currently has a bias to Financials, Industrials and Consumer Discretionary and limited exposure to Utilities, Consumer Staples and Information Technology. While we expect further volatility in the coming months as weak economic data and poor company earnings create uncertainty, we believe that the benefits from global fiscal and monetary stimuli and lower oil prices could lead to resumption in economic growth towards the end of the year. Our proprietary research process is currently highlighting a number of attractive investment opportunities in both the large and mid cap areas of the market. Latest information is available by typing www.blackrock.co.uk/its on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). 24 April 2009
UK 100

Latest directors dealings